PA
Perceptive Advisors Portfolio holdings
AUM
$2.67B
This Quarter Return
+41.54%
1 Year Return
+73.17%
3 Year Return
+837.18%
5 Year Return
+928.4%
10 Year Return
+11,818.46%
AUM
$6.16B
AUM Growth
+$6.16B
(+61%)
Cap. Flow
+$315M
Cap. Flow
% of AUM
5.11%
Top 10 Holdings %
Top 10 Hldgs %
45.74%
Holding
148
New
33
Increased
26
Reduced
17
Closed
23
Top Buys
| 1 |
FMTX
Forma Therapeutics Holdings, Inc. Common Stock
FMTX
|
$58.1M |
| 2 |
Zentalis Pharmaceuticals
ZNTL
|
$45.8M |
| 3 |
ZGNX
Zogenix, Inc.
ZGNX
|
$39.3M |
| 4 |
Lyra Therapeutics
LYRA
|
$36.5M |
| 5 |
MacroGenics
MGNX
|
$36M |
Top Sells
| 1 |
Neurocrine Biosciences
NBIX
|
$112M |
| 2 |
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
|
$62.6M |
| 3 |
Regeneron Pharmaceuticals
REGN
|
$40.5M |
| 4 |
Theravance Biopharma
TBPH
|
$23.1M |
| 5 |
NVRO
NEVRO CORP.
NVRO
|
$22.9M |
Sector Composition
| 1 | Healthcare | 82.47% |
| 2 | Materials | 0.1% |
| 3 | Technology | 0.1% |
| 4 | Consumer Discretionary | 0.02% |
| 5 | Communication Services | 0.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
126
Theravance Biopharma
TBPH
$691M
| – | – |
-1,000,000
| Closed | -$23.1M |
|
127
Protara Therapeutics
TARA
$125M
| – | – |
-8,543
| Closed | -$184K |
|
128
SPDR S&P 500 ETF Trust
SPY
$655B
| – | – |
0
| – | – |
|
129
Schrodinger
SDGR
$1.41B
| – | – |
-250,000
| Closed | -$10.5M |
|
130
Rhythm Pharmaceuticals
RYTM
$6.78B
| – | – |
-170,859
| Closed | -$2.6M |
|
131
Regenxbio
RGNX
$493M
| – | – |
-508,000
| Closed | -$17.1M |
|
132
Moderna
MRNA
$9.28B
| – | – |
0
| – | – |
|
|
MREO
133
Mereo BioPharma
MREO
$273M
| – | – |
-179,419
| Closed | -$187K |
|
134
MEI Pharma
MEIP
$149M
| – | – |
-3,030,440
| Closed | -$4.88M |
|
135
IDEAYA Biosciences
IDYA
$2.25B
| – | – |
-1,141,484
| Closed | -$4.7M |
|
136
Gilead Sciences
GILD
$140B
| – | – |
-1,500,000
| Closed | -$11.2M |
|
137
Denali Therapeutics
DNLI
$2.23B
| – | – |
-850,000
| Closed | -$14.9M |
|
138
AnaptysBio
ANAB
$624M
| – | – |
-500,000
| Closed | -$7.07M |
|
139
Adicet Bio
ACET
$60.4M
| – | – |
-9,306
| Closed | -$10K |
|
140
Abeona Therapeutics
ABEO
$356M
| – | – |
-1,500,000
| Closed | -$3.06M |
|